4.6 Article

Modulation of Calcium-Dependent Inactivation of L-Type Ca2+ Channels via β-Adrenergic Signaling in Thalamocortical Relay Neurons

Journal

PLOS ONE
Volume 6, Issue 12, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0027474

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft [GRK 1167-P1, BU 1019/8-1, DFG Kr1879/3-1]

Ask authors/readers for more resources

Neuronal high-voltage-activated (HVA) Ca2+ channels are rapidly inactivated by a mechanism that is termed Ca2+-dependent inactivation (CDI). In this study we have shown that b-adrenergic receptor (bAR) stimulation inhibits CDI in rat thalamocortical (TC) relay neurons. This effect can be blocked by inhibition of cAMP-dependent protein kinase (PKA) with a cell-permeable inhibitor (myristoylated protein kinase inhibitor-(14-22)-amide) or A-kinase anchor protein (AKAP) St-Ht31 inhibitory peptide, suggesting a critical role of these molecules downstream of the receptor. Moreover, inhibition of protein phosphatases (PP) with okadaic acid revealed the involvement of phosphorylation events in modulation of CDI after bAR stimulation. Double fluorescence immunocytochemistry and pull down experiments further support the idea that modulation of CDI in TC neurons via bAR stimulation requires a protein complex consisting of CaV1.2, PKA and proteins from the AKAP family. All together our data suggest that AKAPs mediate targeting of PKA to L-type Ca2+ channels allowing their phosphorylation and thereby modulation of CDI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

An optimized and validated protocol for inducing chronic experimental autoimmune encephalomyelitis in C57BL/6J mice

Niklas Huntemann, Anna Vogelsang, Linda Groeneweg, Alice Willison, Alexander M. Herrmann, Sven G. Meuth, Susann Eichler

Summary: This study investigates the influence of different components on the progression of experimental autoimmune encephalomyelitis (EAE) and provides a method for consistent EAE induction that reduces the number of mice used while maintaining consistent results.

JOURNAL OF NEUROSCIENCE METHODS (2022)

Editorial Material Clinical Neurology

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-Yes

Leoni Rolfes, Sven G. Meuth

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Biochemistry & Molecular Biology

GABAA Receptor Autoantibodies Decrease GABAergic Synaptic Transmission in the Hippocampal CA3 Network

Amelie F. Menke, Fatme Seval Ismail, Klaus Dornmair, Manuela Cerina, Sven G. Meuth, Nico Melzer

Summary: This study investigated the direct pathogenic effect of GABA(A)R autoantibodies on hippocampal networks and found that they play a crucial role in seizure generation in GABA(A)R autoimmune encephalitis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells

Elham Poonaki, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak, Ulf Dietrich Kahlert

Summary: This study loaded the clinical-stage GLS1 inhibitor Telaglenastat (CB-839) onto PEGylated gold nanoparticles conjugated with the CD133 aptamer (Au-PEG-CD133-CB-839) and tested it on CD133-positive brain tumor models in vitro. The results showed that Au-PEG-CD133-CB-839 significantly reduced the viability of CD133-positive cancer cells, and the effect was stronger compared to individual components of the nanodrug. Interestingly, the treatment was effective in glioblastoma stem cells representing different transcriptomic subtypes. This platform serves as a foundation for further target specificity characterization and in vivo application.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Neurosciences

Hippocampal Cytokine Release in Experimental Epileptogenesis-A Longitudinal In Vivo Microdialysis Study

Kai Siebenbrodt, Vanessa Schuetz, Lara S. Costard, Valentin Neubert, Daniel Alvarez-Fischer, Kerstin Seidel, Bernd Schmeck, Sven G. Meuth, Felix Rosenow, Sebastian Bauer

Summary: This study quantified the release levels of hippocampal extracellular cytokines and chemokines in a rat model of mesial temporal lobe epilepsy with hippocampal sclerosis using microdialysis. The results showed that IL-1 beta release kinetics are consistent with its pro-epileptogenic properties, while IL-10 release kinetics suggest a counter-regulatory effect.

BRAIN SCIENCES (2022)

Review Biochemistry & Molecular Biology

Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol - starting point for PET tracer development

Marvin Korff, Ruben Steigerwald, Elena Bechthold, Dirk Schepmann, Julian A. Schreiber, Sven G. Meuth, Guiscard Seebohm, Bernhard Wuensch

Summary: GluN2B-NMDA receptors play a key role in neurological and neurodegenerative disorders. A new GluN2B-NMDA receptor modulator was developed with promising affinity and pharmacological activity, which could be suitable for human application.

BIOLOGICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial

Theresia Sarabhai, Lucia Mastrototaro, Sabine Kahl, Gidon J. Boenhof, Marc Jonuscheit, Pavel Bobrov, Hisayuki Katsuyama, Rainer Guthoff, Martin Wolkersdorfer, Christian Herder, Sven G. Meuth, Sven Dreyer, Michael Roden

Summary: This study aimed to examine the effects of hyperbaric oxygen therapy on whole-body glucose metabolism in individuals with type 2 diabetes. The results showed that hyperbaric oxygen therapy decreased fasting blood glucose, improved whole-body insulin sensitivity, and achieved this improvement through decreasing endoplasmic reticulum stress and increasing mitochondrial function.

DIABETOLOGIA (2023)

Article Cardiac & Cardiovascular Systems

Total atrial conduction time provides novel information in prediction for stroke in patients with sinus rhythm

A. G. Bejinariu, M. Schilling, P. Mueller, L. Clasen, S. Gerguri, S. Angendohr, S. Katsianos, J. Schmidt, C. Brinkmeyer, S. G. Meuth, M. Kelm, H. Makimoto

Summary: The total atrial conduction time (TACT) measured by echocardiography can predict the risk of atrial fibrillation (AF) and stroke; adding TACT to the revised Framingham stroke risk profile (rFSRP) significantly improves the prediction of stroke incidence.

HEART AND VESSELS (2023)

Article Immunology

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

Steffen Pfeuffer, Leoni Rolfes, Timo Wirth, Falk Steffen, Marc Pawlitzki, Andreas Schulte-Mecklenbeck, Catharina C. Gross, Marcus Brand, Stefan Bittner, Tobias Ruck, Luisa Klotz, Heinz Wiendl, Sven G. Meuth

Summary: Immunoadsorption demonstrated better outcomes compared to double-dose methylprednisolone for treating steroid-refractory acute multiple sclerosis relapses, and modulation of B cell function may be a potential mechanism of action for immunoadsorption.

JOURNAL OF NEUROINFLAMMATION (2022)

Article Clinical Neurology

Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin

Harald Hefter, Dietmar Rosenthal, Alexander Jansen, Raphaela Brauns, Beyza Urer, Hans Bigalke, Hans-Peter Hartung, Sven G. Meuth, John-Ih Lee, Philipp Albrecht, Sara Samadzadeh

Summary: The study found that frequent injections of a complex protein-containing BoNT/A preparation are associated with a significantly higher risk of developing neutralizing antibodies (NABs) compared to injections with a complex protein-free BoNT/A preparation.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Association of obesity with disease outcome in multiple sclerosis

Isabel Lutfullin, Maria Eveslage, Stefan Bittner, Gisela Antony, Martina Flaskamp, Felix Luessi, Anke Salmen, Barbara Gisevius, Luisa Klotz, Catharina Korsukewitz, Achim Berthele, Sergiu Groppa, Florian Then Bergh, Brigitte Wildemann, Antonios Bayas, Hayrettin Tumani, Sven G. Meuth, Corinna Trebst, Uwe K. Zettl, Friedemann Paul, Christoph Heesen, Tania Kuempfel, Ralf Gold, Bernhard Hemmer, Frauke Zipp, Heinz Wiendl, Jan D. Luenemann

Summary: Obesity is associated with higher disease severity and poorer outcome in newly diagnosed patients with multiple sclerosis. The presence of obesity at disease onset is linked to higher disability at baseline and at follow-up periods of 2, 4, and 6 years. Obesity management could potentially improve the clinical outcome of multiple sclerosis.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

A novel NMDA receptor test model based on hiPSC-derived neural cells

Paul Disse, Isabel Aymanns, Nadine Ritter, Stefan Peischard, Lisanne Korn, Heinz Wiendl, Matthias Pawlowski, Stjepana Kovac, Sven G. Meuth, Thomas Budde, Nathalie Strutz-Seebohm, Bernhard Wunsch, Guiscard Seebohm

Summary: N-Methyl-D-aspartate receptors (NMDARs) are crucial for brain learning and information processing. Dysfunction of NMDARs can contribute to neurodegeneration and drug addiction. Developing selective NMDAR modulators is a promising approach for treating these diseases. We established a hiPSC-derived neural cell system to investigate the effects of NMDAR modulators and pharmaceuticals on human neurons.

BIOLOGICAL CHEMISTRY (2023)

Article Immunology

Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers

Amelie Semmler, Anna Katharina Mundorf, Anna Sabrina Kuechler, Karin Schulze-Bosse, Harald Heidecke, Kai Schulze-Forster, Matthias Schott, Markus Uhrberg, Sandra Weinhold, Karl J. Lackner, Marc Pawlitzki, Sven Guenther Meuth, Fritz Boege, Jana Ruhrlaender

Summary: SARS-CoV-2 mRNA vaccination may lead to chronic fatigue/dysautonomia known as post-acute COVID-19 vaccination syndrome (PACVS). Receptor autoantibodies and interleukin-6 (IL-6) were identified as somatic correlates of PACVS. Diagnostic blood markers, including increased Angiotensin II type 1 receptor antibodies, decreased alpha-2B adrenergic receptor antibodies, and elevated IL-6, can distinguish PACVS from normal post-vaccination state.

VACCINES (2023)

Meeting Abstract Clinical Neurology

Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients

Sindhu Ramchandren, Jeff Guptill, Carlo Antozzi, Vera Bril, Josep Gamez, Sven Meuth, Richard Nowak, Dianna Quan, Maria Teresa Sevilla Mantecon, Leona Ling, Yaowei Zhu, Keith Karcher, Hong Sun

NEUROLOGY (2022)

Meeting Abstract Physiology

Effects of kallikrein on central neurons

N. Rychlik, H. -C. Pape, S. G. Meuth, T. Budde

ACTA PHYSIOLOGICA (2022)

No Data Available